Eris partners with 3S Bio Group of China for TPIAO
Eris signs an agreement with Shenyang Sunshine Pharmaceutical Co. Ltd, a part of 3SBio group of China for bringing to India TPIAO.
TPIAO is a formulation used for stimulating the body for producing more platelets, especially useful for cancer patients undergoing chemotherapy or radiation who often face platelet decline. The formulation has non-oncological applications as well.
Eris is currently pursuing Indian regulatory approvals for the formulation.